Heller_2014_Arch.Pharm.(Weinheim)_347_707

Reference

Title : Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases - Heller_2014_Arch.Pharm.(Weinheim)_347_707
Author(s) : Heller L , Schwarz S , Weber BA , Csuk R
Ref : Arch Pharm (Weinheim) , 347 :707 , 2014
Abstract :

Gypsogenin (1) was obtained by acidic hydrolysis from its saponin. While the parent compound 1 acted as a selective inhibitor for butyrylcholinesterase (from equus) possessing a moderate mixed-type inhibition of the enzyme, Ki values as low as 2.67 +/- 0.59 muM were determined for (3beta,4alpha) 3-O-acetyl-olean-12-ene-23,28-dinitrile (11) and acetylcholinesterase (AChE, from electric eel). Thus, 11 possesses one-fifth of the inhibitory activity of the "gold standard" galantamine hydrobromide; this compound is one of the first pentacyclic triterpenoids described as a potent AChE-selective inhibitor.

PubMedSearch : Heller_2014_Arch.Pharm.(Weinheim)_347_707
PubMedID: 25042600

Related information

Citations formats

Heller L, Schwarz S, Weber BA, Csuk R (2014)
Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases
Arch Pharm (Weinheim) 347 :707

Heller L, Schwarz S, Weber BA, Csuk R (2014)
Arch Pharm (Weinheim) 347 :707